No relevant pages have been found.
of the Prospective Outcomes in Sporadic versus Hereditary breast cancer (POSH) study, which included 2850 women under age 41 years who were diagnosed...
drug may help women with hereditary breast cancer... clinical trial of a new drug designed to treat hereditary breast cancer has achieved promising results, UK scientists have... hereditary breast cancer, PARP inhibitors,...
No relevant news have been found.